Study Findings On ADHD Treatments Presented At Psychiatric Meeting
Links shared publicly online about this topic.
- 1,639total visits
Study Findings On ADHD Treatments Presented At Psychiatric Meeting
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, has announced that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) t
View full resource at medicalnewstoday.com
Tags: ADHD, Disease and Condition, Shire
Most Recently Shared on October 30, 2009 at 3:30 pm By:
Study Findings On ADHD Treatments Presented At Psychiatric Meeting: Shire plc (LSE: SHP, NASDAQ: SHPGY), the gl.. http://bit.ly/tDMfR
Study Findings On ADHD Treatments Presented At Psychiatric Meeting
medicalnewstoday.com — “Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, has announced that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) t” View full resource at medicalnewstoday.com
Most Recently Shared on October 30, 2009 at 3:59 pm By:
MNT Psychology News Health News
Study Findings On ADHD Treatments Presented At Psychiatric Meeting: Shire plc (LSE: SHP, NASDAQ: SHPGY), the gl.. http://bit.ly/2g2hjD
Advertisement
